Rapid screening of toxic salbutamol, ractopamine, and clenbuterol in pork sample by high-performance liquid chromatography—UV method  by Yan, Kunping et al.
ww.sciencedirect.com
j o u r n a l o f f o o d and d ru g an a l y s i s 2 4 ( 2 0 1 6 ) 2 7 7e2 8 3Available online at wScienceDirect
journal homepage: www.j fda-onl ine.comOriginal ArticleRapid screening of toxic salbutamol, ractopamine,
and clenbuterol in pork sample by high-
performance liquid chromatographydUV methodKunping Yan a,b,*,1, Huiqun Zhang a,1, Wenli Hui a, Hongli Zhu a,b,
Xinbo Li a, Fangyi Zhong a, Xiu'e Tong c, Chao Chen a,d,*
a College of Life Science, Northwest University, Xi'an, PR China
b Shaanxi Lifegen Co., Ltd, Xi'an, PR China
c Weinan Products Quality Supervision and Inspection Institute, Weinan, PR China
d National Engineering Research Center for Miniaturized Detection System, Xi'an, PR Chinaa r t i c l e i n f o
Article history:
Received 16 December 2014
Received in revised form
15 June 2015
Accepted 4 December 2015
Available online 23 February 2016
Keywords:
b-agonist
clenbuterol
high-performance liquid
chromatographyeUV
pork
ractopamine
salbutamol* Corresponding authors. 229 Taibai North R
E-mail addresses: kpyan@nwu.edu.cn (K.
1 These two authors contributed equally t
http://dx.doi.org/10.1016/j.jfda.2015.12.002
1021-9498/Copyright © 2016, Food and Drug Adm
BY-NC-ND license (http://creativecommons.orga b s t r a c t
A rapid and simple high-performance liquid chromatographyeUV method was developed
for the separation and quantification of salbutamol, ractopamine, and clenbuterol in pork.
A mixture of acetonitrileeformic acideammonium acetate was used as the mobile phase to
separate three b-agonists on a C18 column with gradient. The effects of the addition of
formic acid and ammonium acetate to mobile phases on the separation of b-agonists were
investigated. These additives can greatly improve the resolution and sensitivity. Under the
optimized chromatographic condition, this separation does not need extra sample prep-
aration. Complete baseline separation of three b-agonists was achieved in < 20 minutes;
the linear range is 0.2e50 mg/L with a correlation coefficient R2 value of > 0.99. Excellent
method reproducibility was found by intra- and interday precisions with a relative stan-
dard deviation of < 3%. The detection limit (S/N ¼ 3) was found to be <0.05 mg/L; this
method can be used for routine screening of the b-agonist residues in foods of animal
origin before being identified by confirmatory methods.
Copyright © 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Вntr-agonists are phenyl ethanolamines with different sub-
stituents on the aromatic ring and on the terminal amino
group. These molecules have a powerful pharmacologicald, 386 Mail Box, Xi'an 710
Yan), cchen898@nwu.ed
o this study.
inistration, Taiwan. Publis
/licenses/by-nc-nd/3.0/).activity [1]. The main applications in human and veterinary
medicine are as tocolytic and bronchodilator agents [2].
However, these compounds are also used as growth pro-
moters in livestock to increase the lean meat-to-fat ratio and
improve feed conversion efficiency [3]. Numerous literatures069, China.
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of b-agonists, including cardiac palpitation, tachycardia,
nervousness, muscle tremors, and confusion [4]. Therefore,
no b-agonists have been permitted in most countries for
growth-promoting purposes in farm animals. Therefore, in-
spection of b-agonists is very important in the food industry.
A survey found that the levels of residues of b-agonists
have decreased over the years due to optimization of admin-
istration schemes and application of comedication to avoid
detection. Many laboratories now use a combination of
screening and confirmatory methods to cope with a relatively
large number of samples and to increase the reliability of the
final result [5]. Confirmatory methods include liquid chro-
matography/tandem mass spectrometry [6e8] and gas chro-
matographyemass spectrometry [9,10]. These confirmatory
methods based on chromatographic approaches can provide
both qualitative and quantitative detection results with
satisfactory sensitivity and reproducibility. However, they
require expensive instrumentation, and thus are not suitable
for routine inspection.
As alternatives of confirmatory methods, various routine
screening methods for the determination of b-agonist resi-
dues in animal tissue and body fluids have been developed.
These methods use immunoassay [11e14], capillary electro-
phoresis [15], electrochemical sensors [11,16,17], surface
plasmon resonance [18], supercritical fluid chromatography
[19], chemiluminescence [20], molecularly imprinted poly-
mers [21e23], and high-performance liquid chromatography
(HPLC)eUVmethods [24]. Among them,HPLCeUV is one of the
most widely used methods in all the inspection centers and
laboratories, but the current established methods need sam-
ple clean-up steps or are able to determine only one b-agonist
in one chromatographic run [24e27].
This work was to develop a simple HPLCeUV analytical
method for simultaneous determination of several b-agonists
without extra sample clean-up steps for routine analysis,
which can be used as a screening method for the detection of
b-agonists before being identified by confirmatory methods.
The linearity of calibration curve, recovery, precision, and
lower limit of detection were studied to evaluate the devel-
oped method. The method was successfully used to deter-
mine the content of b-agonist residues in pork.Table 1 e Gradients used for liquid chromatography.
Time (min) Eluent A (%) Eluent B (%) Eluent C (%)
0.01 71 4 25
6 55 20 25
19 52 23 252. Methods
2.1. Chemicals, standard solutions, and materials
Three b-agonist standards, including salbutamol (SAL), rac-
topamine (RAC), and clenbuterol (CLB), were purchased from
the laboratories of Dr. Ehrenstorfer (Augsburg, Germany).
Methanol and acetonitrile (HPLC grade) were purchased from
the Thermo Fisher Scientific Inc (Fairlawn, NJ, USA); b-glucu-
ronidase/aryl sulfatase was purchased from Roche Diag-
nostica GmbH (Mannhein, Germany). Formic acid (HPLC
grade) was obtained from Tedia Company Inc. (Fairfield, OH,
USA). Hydrochloric acid and sodium hydroxide were obtained
from Sinopharm Chemical Reagents Co., Ltd (Shanghai,
China). Ammonium acetate and sodium acetate were ob-
tained from Tianjin Chemical Reagents Company (Tianjin,China). Deionized water was prepared using a Milli-Q water
filtration system (EMD Millipore Corp., Billerica, MA, USA). All
solvents for HPLC were filtered through 0.45 mm filters (Mil-
lipore Corp.) and degassed in an ultrasonic bath.
Stock solutions of the three b-agonists were prepared by
dissolving 5 mg of each compound in 50 mL methanol. The
standard solutions were prepared by diluting the stock solu-
tions to 1 mg/mL. As sample matrixes, pork were obtained
from supermarkets, free markets, and street vendors, and
preserved at 20C until use.
2.2. Sample preparation from tissue
In pork, b-agonists were extracted using a previously reported
method with minor modification [10]. Briefly, aliquots of 2 g
finely homogenized pork were transferred into 50 mL conical
glass flasks. Eight milliliters of 0.2 mol/L sodium acetate and
50 mL of b-glucuronidase/aryl sulfatase were added andmixed.
It was incubated at 37C for 12 hours. The homogenate was
then centrifuged at 132 000 g for 10 minutes, and the super-
natant was recovered and transferred to a 50 mL flask. The
tissue residue was washed with 5 mL sodium acetate,
repeated twice. Then 5mL 0.1mol/L perchloric acidwas added
into 4 mL supernatant, and the pH was adjusted to 1.0 with
1.0 mol/L perchloric acid. The mixture was centrifuged at
132 000 g for 10 minutes again. The supernatant was trans-
ferred into another 50 mL centrifuge tube, and the pH was
adjusted to 11 with 10 mol/L sodium hydroxide. The mixture
was completely extracted with a mixed solution of 10 mL
saturated sodium chloride solution and isopropanoleethyl
acetate (6:4, v/v). Then the supernatant was centrifuged at
132 000 g for 10 minutes. The organic phase was transferred
into another centrifuge tube, dried under a gentle nitrogen
stream, and reconstituted to 1.0 mL with methanol/water
containing 0.1% formic acid (1/9, v/v) followed by filtering
through 0.22 mm organic filters for HPLC analysis.
2.3. Analysis of b-agonists by HPLC
The analyses were carried using an Agilent Technologies
HP1200 series HPLC system equipped with a quaternary
gradient pump, a diode array detector, and a Chemstation
data-analysis system (Agilent, Palo Alto, CA, USA). Chro-
matographic separation was performed at 25C on Agilent
Eclipse C18 (250 mm  4.6 mm i.d., 5 mm particle) analytical
columns (Agilent) at a flow rate of 0.8 mL/min via a ternary
gradient. Eluent A consisted of 0.1% formic acid, eluent B is
0.1% formic acid in acetonitrile solution, and eluent C is
50 mmol/L ammonium acetate aqueous solution. Separation
was performed with a gradient, as shown in Table 1. The in-
jection volumewas 20 mL, and the detection wavelength of the
detector was set at 225 nm [28].
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The linear correlation and dynamic range of b-agonist
detection were determined from calibration curves gener-
ated by serial analysis of b-agonist standards. A calibration
curve for each compoundwas calculated based on peak areas
obtained by serially injecting 20 mL of methanol-diluted so-
lutions of b-agonist standards. Stock solutions of individual
b-agonists were serially diluted and spiked into matrix so-
lution extracted from the pork. The lowest detection limits
were determined as concentrations corresponding to three
times of noise (S/N ¼ 3).2.5. Precision
The precision of the method was evaluated using b-agonist-
spiked samples. Five extractions of the same b-agonist-spiked
tissue sample were tested consecutively to determine
intraday relative standard deviations (RSDs). For interday
precision, five extractions of the same b-agonist-spiked tissue
sample were tested in three sequences over 5 days.Figure 1 e Representative chromatograms for (A) standards, (B) b
A, 0.5% formic acid; eluent B, 0.5% formic acid in acetonitrile; and
shown in Table 1. CLB ¼ clenbuterol; RAC ¼ ractopamine; SAL2.6. Recovery
The recovery of the assay was determined by spiking known
amounts of standards into test samples. Nine b-agonist-
spiked samples and nine control samples were compared. For
pork samples, 2 mg, 0.8 mg, or 0.16 mg of the three b-agonists
were directly spiked into 2.0 g tissues. The extraction of b-
agonists was performed as described in the “Sample prepa-
ration from tissue” section. The control samples were sub-
jected to the same procedure as test samples.3. Results
3.1. Method specificity
Complete baseline separation of three b-agonists was ach-
ieved in < 20 minutes. The chromatogram of standards is
shown in Figure 1A. The retention times for SAL, RAC, and CLB
were 7.92 minutes, 13.09 minutes, and 16.88 minutes,
respectively. The optimized gradient is shown in Table 1.lank samples, and (C) spiked sample. Mobile phase: eluent
eluent C, 50 mmol/L ammonium acetate. The gradients are
¼ salbutamol.
Table 2 e Linear correlation, ranges, and lower limit of detection of b-agonists selected.
Standard Regression equation Coefficient (R2) Linear range (mg/L) Limita (mg/L)
SAL y ¼ 739.36x þ 9907.5 0.9970 0.2e25 0.02
RAC y ¼ 632.53x  10048 0.9992 0.4e50 0.05
CLB y ¼ 713.86x  12933 0.9901 0.4e50 0.05
CLB ¼ clenbuterol; RAC ¼ ractopamine; SAL ¼ salbutamol.
a S/N ¼ 3.
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shown in Figures 1B and 1C. The b-agonists were not detected
in blank samples, and no interference peaks were observed at
the retention time of b-agonist standards. All the spiked b-
agonist standards were well separated and detected with low-
abundance peaks frommatrix partially overlappedwith the b-
agonists. The quantitative results were still satisfactory
because interference from the overlapped peakswasminimal.3.2. Linear range and limit of detection
Under optimized conditions, the linear ranges were 0.2e25 mg/
L for SAL and 0.4e50 mg/L for RAC and CLB. The correlation
coefficients of calibration curves were > 0.99. The lower limits
of detectionwere calculated based on a signal-to-noise ratio of
3, and the values varied from 0.02 mg/L to 0.05 mg/L (Table 2).
The method provides sensitive detection with a wide linear
range.3.3. Precision
Five samples extracted from the same b-agonist-spiked tissue
(0.008 mg/g) were analyzed consecutively and also in different
days (d ¼ 5, n ¼ 5). The precision was high for both intraday
(RSD values 1.61e1.95%) and interday (RSD values 2.74e2.98%)
assays. The results are summarized in Table 3. Both inter- and
intraday RSDs are < 3%, indicating a high degree of assay
precision and reproducibility.3.4. Recovery
Different sampleswere selected formaximumvariability with
respect to provenance. Spiked samples at three levels (1.0 mg/
g, 0.4 mg/g, or 0.008 mg/g of tissue) were analyzed to evaluate
the recovery (Table 4). Excellent recoveries of 84.9e91.9% for
spiking 1.0 mg/g samples and less satisfactory recoveries ofTable 3 e Analysis precisionsa for each b-agonist
compound.
Standard Intraday RSD
(%, n ¼ 5)
Interday RSD
(%, n ¼ 5)
SAL 1.61 2.74
RAC 1.83 2.85
CLB 1.95 2.98
CLB ¼ clenbuterol; RAC ¼ ractopamine; RSD ¼ relative standard
deviation; SAL ¼ salbutamol.
a Spiking 0.008 mg/g in the tissue sample.90.1e82.5% and 79.2e88.4% for spiking, respectively, 0.4 mg/g
and 0.008 mg/g samples were obtained.
3.5. Application to samples
The method was used to analyze 142 pork samples from the
local Food and Drug Administration. The samples were
randomly obtained from supermarkets, free markets, and
street vendors of the entire Shaanxi Province in China, ac-
cording to the local government monitoring plan. Five sam-
ples collected from free markets were detected to contain b-
agonist residues. The SAL contents of two positive samples
were 0.14 mg/kg and 1.13 mg/kg. The RAC contents of two
positive samples were 0.27 mg/kg and 0.87 mg/kg. The CLB
content of one positive sample was 0.65 mg/kg. The results
were consistent with that of the local Food and Drug Admin-
istration and showed that this method was able to screen
samples for b-agonists routinely before performing confir-
matory tests.4. Discussion
SAL and CLB have a similar molecular structure except for
different substituent groups on the aromatic ring, but have a
significant difference with RAC. These lead to their various
hydrophobicity scales, making them difficult to be separated
in a short high-performance liquid chromatography pro-
gram. In this study, mixtures of acetonitrileeformic acid-
eammonium acetate were evaluated for their potential to
separate b-agonists in a complex matrix. When taking water
and acetonitrile as the mobile phase, all the peaks of b-
agonist were severely trailing and split into two or more
peaks (Figure 2A). The possible reason for multiple peaks,
besides a hydrophobic interaction, is that three agonists in
this mobile phase can be charged, leading to an ion exchange
interaction. Two different interactions lead to the split peaks.
No trailing of CLB peak was observed and the peak becameTable 4 e Recovery of b-agonists from pork.
Standard % Recovery
Spiking
1.0 mg/g
Spiking
0.4 mg/g
Spiking
0.08 mg/g
SAL 91.9 ± 7.8 90.1 ± 7.1 88.4 ± 6.5
RAC 89.3 ± 5.4 88.3 ± 5.2 85.6 ± 4.8
CLB 84.9 ± 4.7 82.5 ± 5.5 79.2 ± 5.9
CLB ¼ clenbuterol; RAC ¼ ractopamine; SAL ¼ salbutamol.
Figure 2 e Chromatograms of b-agonist standards by different mobile phases. Mobile phase: (A) eluent A, water; eluent B,
acetonitrile; and eluent C, water; (B) eluent A, 0.05% formic acid; eluent B, 0.05% formic acid in acetonitrile; and eluent C,
0.05% formic acid; (C) eluent A, 0.5% formic acid; eluent B, 0.5% formic acid in acetonitrile; and eluent C, 0.5% formic acid. The
gradients are shown in Table 1. CLB ¼ clenbuterol; RAC ¼ ractopamine; SAL ¼ salbutamol.
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tion), although the peaks corresponding to SAL and RACwere
still split into two peaks (Figure 2B). With the increasing the
formic acid concentration to 0.5%, the ion exchange inter-
action also became weak, and the peaks of SAL and CLB both
became sharper (Figure 2C). We continued to increase formic
acid concentration to improve the RAC peak shape, but as
evident from the results, higher concentrations of formic
acid had no further effect on it. Therefore, we added
ammonium acetate into themobile phase in order to improve
the RAC peak shape. Ammonium acetate solution was used
as the third eluent. When the concentration of ammonium
acetate was 50 mmol/L, RAC also showed one peak
(Figure 1A). It is worth noting that ammonium acetate caused
broadening of the peaks of SAL and CLB, and decreased their
sensitivity.
Most of the reported HPLC methods for b-agonist separa-
tion used inorganic acids or salts as an additive to improve the
peaks' resolution or shape. In this method, we used formic
acid and ammonium acetate as the mobile phase additive,
which are easily soluble in organic solvents. When the pro-
portion of water in the mobile phase is low, inorganic acids or
salts easily precipitate from the mobile phase; these very tinyprecipitate particles can damage the pump head of HPLC in-
strument [29]. Therefore, it is very important to HPLC instru-
ment to use organic additives that can be soluble in solvents.
In addition, organic additives are compatible with mass
spectrum and can be applied in the liquid chromatogra-
phyemass spectrometry or gas chromatographyemass spec-
trometry. Compared with this method, most of the published
HPLCeUV and other methods need extra sample clean-up
steps, such as solid-phase extraction [24] and solid-phase
microextraction [28]; these complex methods need more
sample preparation time and may reduce the recovery. After
the optimization of themethod, sensitivity and quantification
limits are slightly higher than the other HPLCeUV methods
[26e28].
The extraction procedure for b-agonists did not need extra
sample clean-up step, which reduced the sample preparation
time. Moreover, as an additive in the mobile phase, formic
acid and ammonium acetate can improve the resolution and
sensitivity of three b-agonists. Quantitative data showed good
precision, linear range, and limit of detection. Themethod can
also be successfully applied to the 142 samples. Results sug-
gested that this method can be used as a screening method to
detect b-agonists.
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